Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Rituximab Efficiency and Tolerance in Treatment of Bullous Pemphigoid.

NCT00525616 is registered in ClinicalTrials.gov with University Hospital, Rouen as lead sponsor.

NCT NCT00525616
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00525616 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Rituximab Efficiency and Tolerance in Treatment of Bullous Pemphigoid.
Lead sponsor
University Hospital, Rouen
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2008
Completion date
December 31, 2013
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bullous pemphigoid